Connection

Gerhard Hindricks to Stroke

This is a "connection" page, showing publications Gerhard Hindricks has written about Stroke.
Connection Strength

0.242
  1. Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation. Adv Ther. 2017 10; 34(10):2274-2294.
    View in: PubMed
    Score: 0.133
  2. Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation. Eur Heart J. 2018 08 21; 39(32):2942-2955.
    View in: PubMed
    Score: 0.035
  3. The Optimal Anti-Coagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) trial. Am Heart J. 2018 03; 197:124-132.
    View in: PubMed
    Score: 0.034
  4. Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation. Europace. 2017 01; 19(1):132-138.
    View in: PubMed
    Score: 0.032
  5. The Year in Cardiology 2016: arrhythmias and cardiac implantable electronic devices. Eur Heart J. 2017 01 21; 38(4):238-246.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.